Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Serra

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agentsEmilie P Buddingh, Marieke L Kuijjer, Ronald A J Duim, et al.
Bioorganic & Medicinal Chemistry|October 5, 2011
Identification of a potent and selective σ₁ receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cellsDaniela Rossi, Alice Pedrali, Mariangela Urbano, et al.
BMC Genomics|February 17, 2022
miR-486-5p expression is regulated by DNA methylation in osteosarcomaHeidi M Namløs, Magne Skårn, Deeqa Ahmed, et al.
The Journal of Pathology|October 1, 2011
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancyFumihiko Nakatani, Manuela Ferracin, Maria Cristina Manara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2011
Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcomaJens H W Pahl, S Eriaty N Ruslan, Emilie P Buddingh, et al.
Oncology Reports|November 6, 2007
Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphomaGianluca Brusa, Elisa Zuffa, Claudia Maria Hattinger, et al.
BMC Medical Genomics|September 22, 2011
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenograftsMarieke L Kuijjer, Heidi M Namløs, Esther I Hauben, et al.
Plos One|November 13, 2012
Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcomaStine H Kresse, Halfdan Rydbeck, Magne Skårn, et al.
BMC Cancer|March 1, 2014
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomasClara Guerzoni, Stefano Amatori, Luca Giorgi, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2011
Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cellsEmilie P Buddingh, Marco W Schilham, S Eriaty N Ruslan, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agentsEmilie P Buddingh, Marieke L Kuijjer, Ronald A J Duim, et al.
Bioorganic & Medicinal Chemistry|October 5, 2011
Identification of a potent and selective σ₁ receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cellsDaniela Rossi, Alice Pedrali, Mariangela Urbano, et al.
BMC Genomics|February 17, 2022
miR-486-5p expression is regulated by DNA methylation in osteosarcomaHeidi M Namløs, Magne Skårn, Deeqa Ahmed, et al.
The Journal of Pathology|October 1, 2011
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancyFumihiko Nakatani, Manuela Ferracin, Maria Cristina Manara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2011
Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcomaJens H W Pahl, S Eriaty N Ruslan, Emilie P Buddingh, et al.
Oncology Reports|November 6, 2007
Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphomaGianluca Brusa, Elisa Zuffa, Claudia Maria Hattinger, et al.
BMC Medical Genomics|September 22, 2011
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenograftsMarieke L Kuijjer, Heidi M Namløs, Esther I Hauben, et al.
Plos One|November 13, 2012
Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcomaStine H Kresse, Halfdan Rydbeck, Magne Skårn, et al.
BMC Cancer|March 1, 2014
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomasClara Guerzoni, Stefano Amatori, Luca Giorgi, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2011
Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cellsEmilie P Buddingh, Marco W Schilham, S Eriaty N Ruslan, et al.
Pageof 16